{"result": {"id": "chatcmpl-968", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Community Structure Analysis - Eye Research\",\n    \"summary\": \"This report analyzes the structure and relationships within a community focused on eye research, including its key entities like researchers, patients, and medical institutions. The community's focus is on understanding and treating eye diseases through innovative treatments and technologies.  The analysis reveals significant connections between these entities, highlighting their interconnectedness in advancing eye health.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The community exhibits a high level of impact due to its direct contribution to human health and the potential for groundbreaking discoveries in ophthalmology.\",\n    \"findings\": [\n        {\n            \"summary\": \"Researchers play a crucial role in developing new treatments and technologies for eye diseases. Their expertise in various fields, including genetics, immunology, and pharmacology, is essential for advancing the field of eye research.\",\n            \"explanation\": \"The community's researchers are at the forefront of innovation, constantly pushing the boundaries of knowledge to develop novel therapies for a wide range of eye conditions.  Their work involves studying the underlying mechanisms of diseases, developing new diagnostic tools, and testing potential treatments in preclinical and clinical trials. The research conducted by these experts directly impacts patients who suffer from various eye disorders.\"\n        },\n        {\n            \"summary\": \"Patients are at the heart of this community's mission. Their participation in clinical trials and access to innovative treatments is crucial for advancing medical knowledge and improving patient outcomes.\",\n            \"explanation\": \"The success of any research project relies heavily on the involvement of patients.  Their willingness to participate in clinical trials provides valuable data that helps researchers understand disease progression, test new therapies, and ultimately develop effective treatments. The community's focus on patient-centric care ensures that their research is driven by a genuine desire to improve the lives of those affected by eye diseases.\"\n        },\n        {\n            \"summary\": \"Medical institutions play a vital role in providing access to cutting-edge treatments and fostering collaboration between researchers, clinicians, and patients.\",\n            \"explanation\": \"The community's medical institutions serve as hubs for research, clinical care, and patient support.  They provide the infrastructure necessary for conducting clinical trials, offering specialized eye care services, and connecting patients with relevant resources. These institutions act as bridges between researchers and patients, facilitating communication and collaboration to accelerate progress in eye health.\"\n        },\n        {\n            \"summary\": \"The community's focus on innovation is evident through its investment in cutting-edge technologies and research initiatives.\",\n            \"explanation\": \"The community invests heavily in developing new technologies and research initiatives that can revolutionize the field of eye care.  This includes advancements in imaging techniques, gene therapy, and artificial intelligence. These innovations have the potential to transform how we diagnose, treat, and manage eye diseases.\"\n        },\n        {\n            \"summary\": \"Collaboration between researchers, clinicians, and patients is essential for driving progress in eye research.\",\n            \"explanation\": \"The community's collaborative approach fosters a synergistic environment where diverse perspectives are valued.  This collaboration allows for the sharing of knowledge, expertise, and resources to accelerate research efforts and develop more effective treatments. The integration of patient feedback into clinical trials ensures that new therapies are developed with their needs and preferences in mind.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743288291, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 696, "prompt_tokens": 2048, "total_tokens": 2744, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1650,CHRRPE,Combined hamartoma of the retina and retinal pigment epithelium,1\n1651,PATIENT,\"The **patient** is a subject of study and medical care, often diagnosed with specific conditions.  They may be experiencing spontaneous cardiac events (cSDHs) or have vision problems like decreased vision in the right eye at age 5. The patient's condition can range from cancer to neurological issues such as brain lesions or metastases. They are included in various studies, including those focusing on the group of patients with a specific condition and those within the GA group.  Furthermore, certain patients may be prescribed statins based on their medical history.  The **patient** is also specifically mentioned in case studies and treatment plans for conditions like brain lesions or brain metastases. \n\",17\n1652,RIGHT EYE,The right eye of the patient,1\n1653,MACULA,A part of the retina,1\n1654,OPTIC DISC,Part of the eye,1\n1655,RECURRENT NONCLEARING HEMORRHAGE,,1\n1656,PRERETINAL VASCULARIZATION,,1\n1657,TUBEROUS SCLEROSIS,,1\n1490,INTRAVITREAL INJECTIONS,\"**INTRAVITREAL INJECTIONS** are a medical procedure used to deliver drugs directly into the **vitreous humor**, the clear fluid inside the eye. This method is employed for treating various **eye diseases**, including age-related macular degeneration (AMD).  The injections are administered directly into the vitreous humor, allowing for targeted treatment of the affected area within the eye. \n\",1\n1658,VITREOUS HEMORRHAGE,,1\n2311,TREATMENT-NAIVE,,1\n2312,TREATMENT-SWITCH,,1\n2767,DURAL BORDER CELL (DBC),,1\n613,BLOOD VESSELS,\"The **blood vessels** are essential structures within the body's circulatory system.  They play a crucial role in transporting oxygen and nutrients to tissues, supporting skeletal muscle development, and facilitating the overall transportation of vital substances throughout the body. These intricate structures, formed by vascular endothelial cells, are sensitive to mechanical stimuli and serve as the primary means of blood transport. They can be found throughout the body, including the dura mater and other areas like the optic nerve (OM).  \n\",4\n1933,TUMOR NEOVASCULARIZATION,\"The **TUMOR NEOVASCULARIZATION** process refers to the formation of new blood vessels within a tumor. This process is crucial for tumor growth and progression, as it provides the necessary supply of nutrients and oxygen to support rapid cell proliferation.  Furthermore, the regulation of this process plays a significant role in controlling tumor angiogenesis, which can be both beneficial and detrimental depending on the context. \n\",4\n1934,BIOMECHANICAL FORCES,,3\n938,TUMOR PROGRESSION,\"**Tumor progression** encompasses the growth and spread of a tumor. This process involves various stages, including tumor cell proliferation, invasion into surrounding tissues, and potentially metastasis to distant organs.  It also includes angiogenesis, the formation of new blood vessels that supply the growing tumor with nutrients and oxygen. \n\",2\n2763,OM,\"The **OM** (Optic Media) refers to a variety of structures depending on context.  In the context of the brain, it can be considered as part of the dura mater's outer membrane or even another component of brain tissue itself.  It is also closely related to the optic nerve and its function. \n\",4\n2764,NORMAL CONTROL PARTICIPANT,A person without a history of cSDHs,2\n2766,DURA MATER,Dura mater of the brain,2\n1331,GABA,,3\n1937,CHANCICAL FORCES,Forces that regulate tumor neovascularization,1\n2760,CHRONIC SUBDURAL HEMATOMA,A type of brain bleed,2\n2761,DURAMATER,The dura mater is the outer membrane of the skull,3\n2765,PATIENT WITH REPEAT SPONTANEOUS CSDH,A person with a history of cSDHs,2\n532,LUNG CANCER,\"Lung cancer is a type of cancer that affects the lungs. It has been linked to disruptions in the function of gamma-aminobutyric acid (GABA), a neurotransmitter known for its calming effects on the brain. \n\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n637,CHRRPE,PATIENT,The patient was diagnosed with CHRRPE,18\n638,PATIENT,RIGHT EYE,The right eye of the patient is affected by CHRRPE,18\n639,PATIENT,MACULA,The macula of the patient is affected by CHRRPE,18\n640,PATIENT,OPTIC DISC,The optic disc of the patient is affected by CHRRPE,18\n642,PATIENT,RECURRENT NONCLEARING HEMORRHAGE,The patient experienced recurrent nonclearing hemorrhage after the initial presentation,18\n643,PATIENT,PRERETINAL VASCULARIZATION,The patient experienced preretinal vascularization,18\n644,PATIENT,TUBEROUS SCLEROSIS,The patient's family history was negative for tuberous sclerosis,18\n645,PATIENT,INTRAVITREAL INJECTIONS,The patient received intravitreal injections of bevacizumab,18\n646,PATIENT,VITREOUS HEMORRHAGE,The patient experienced vitreous hemorrhage after the initial presentation,18\n922,TREATMENT-NAIVE,PATIENT,Patients who have never received treatment before,18\n923,PATIENT,TREATMENT-SWITCH,Patients who switched from another treatment to Brolucizumab,18\n1141,PATIENT,DURAL BORDER CELL (DBC),The patient's dural border cells were studied,18\n737,BLOOD VESSELS,TUMOR NEOVASCULARIZATION,Tumor neovascularization is regulated by blood vessel sensitivity to mechanical stimuli,8\n738,TUMOR NEOVASCULARIZATION,BIOMECHANICAL FORCES,Biomechanical forces can affect the regulation of tumor neovascularization,7\n736,TUMOR PROGRESSION,TUMOR NEOVASCULARIZATION,Tumor progression can be regulated by tumor neovascularization,6\n740,BIOMECHANICAL FORCES,BIOMECHANICAL FORCES,Biomechanical forces are used in combination with anti-angiogenic therapies for tumor treatment,6\n1137,OM,NORMAL CONTROL PARTICIPANT,A normal control participant's outer membrane was used for study,6\n1143,DURA MATER,BLOOD VESSELS,\"The dura mater had a higher concentration of blood vessels than the OM\nThe dura mater and OM were analyzed for blood vessels\",6\n479,GABA,TUMOR PROGRESSION,GABA derived from tumor cells promotes tumor progression,5\n739,CHANCICAL FORCES,TUMOR NEOVASCULARIZATION,Chmical forces regulate tumor neovascularization,5\n1133,CHRONIC SUBDURAL HEMATOMA,DURAMATER,Chronic subdural hematomas are studied in the dura mater,5\n1135,DURAMATER,NORMAL CONTROL PARTICIPANT,A normal control participant's dura mater was used for study,5\n1136,DURAMATER,PATIENT WITH REPEAT SPONTANEOUS CSDH,The patient with repeat spontaneous cSDHs had their dura mater studied,5\n480,GABA,LUNG CANCER,Targeting GABA and its signaling pathway may represent a potential therapy for lung cancer,4\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_ca82009c835dea39f3eb5800bc58d1e590b56892764278d6337bc8dc8b2ffae8_v2"}